The much-awaited Sudeep Pharma IPO is all set to hit the primary market on November 21, 2025, and will remain open for subscription till November 25, 2025. Backed by strong revenue growth, stable profitability, and leadership in excipients and specialty ingredients, the company is looking to raise ₹895 crore through this public issue.
This IPO includes a fresh issue worth ₹95 crore and an offer for sale (OFS) of 1,34,90,726 equity shares. The price band has been fixed at ₹563–₹593 per share, making it one of the notable mid-sized IPOs of the year.
With a solid presence in over 100 countries and a diversified portfolio of more than 200 products, Sudeep Pharma is positioning itself strongly for future expansion.
🚀 Key IPO Highlights
-
IPO Open Date: November 21, 2025
-
IPO Close Date: November 25, 2025
-
Price Band: ₹563–₹593
-
Issue Size: Approx ₹895 crore
-
Fresh Issue: ₹95 crore
-
OFS: 1.34 crore shares
-
Face Value: ₹1
-
Listing: BSE & NSE – November 28, 2025
-
Allotment Date: November 26, 2025
The retail quota stands at 35%, QIB at 50%, and NII at 15%.
📊 Financial Performance: Consistent Growth
Sudeep Pharma has posted impressive financial numbers over the last three years.
Revenue Growth (₹ Crore)
-
2024: ₹465.38
-
2025: ₹511.33
Profit After Tax
-
2024: ₹133.15 crore
-
2025: ₹138.69 crore
Why This Matters
The company’s PAT margin of 27%, ROE of 28%, and EBITDA margin of nearly 40% position it among the more profitable players in the speciality chemical & pharma-ingredient space.
Analysts believe the long-term outlook looks strong, backed by consistent demand from pharma, food, and nutrition industries.
🏭 About Sudeep Pharma
Established in 1989, Sudeep Pharma is a top manufacturer of excipients, specialty ingredients, and mineral salts used across pharmaceutical, food, and nutrition brands globally.
Business Verticals
-
Pharma, Food & Nutrition Ingredients
-
Calcium, Zinc, Iron, Potassium, Magnesium, Sodium, Copper salts
-
-
Specialty Ingredients
-
Micronutrient premixes
-
Encapsulated & granulated minerals
-
Triturated blends
-
The company operates six manufacturing units with a combined capacity of 50,000 MT, supported by in-house technologies such as encapsulation, spray drying, granulation, and liposomal preparation.
📦 Market Lot & Minimum Investment
| Category | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Min | 1 | 25 | ₹14,825 |
| Retail Max | 13 | 325 | ₹1,92,725 |
| S-HNI Min | 14 | 350 | ₹2,07,550 |
| B-HNI Min | 68 | 1,700 | ₹10,08,100 |
🎯 Use of IPO Proceeds
| Purpose | Amount (₹ Cr) |
|---|---|
| Machinery & Capex for Nandesari Facility I | 75.81 |
| General Corporate Purposes | Remaining |
🧮 Valuation Snapshot (FY2025)
| Metric | Value |
|---|---|
| ROE | 28.13% |
| ROCE | 29.82% |
| EBITDA Margin | 39.70% |
| PAT Margin | 27.63% |
| Debt-to-Equity | 0.20 |
| EPS | ₹12.78 |
| NAV | ₹45.86 |
🧐 Should You Apply? — IPO Review
Sudeep Pharma shows:
✔ Strong financial performance
✔ High margins and efficient operations
✔ Global market presence
✔ Consistent product demand
✔ Low debt levels
Verdict:
👉 Suitable for long-term investors looking for stable growth in the pharma-ingredient sector.
👉 GMP updates will further signal listing expectations.
📅 Important Dates
| Event | Date |
|---|---|
| IPO Open | Nov 21, 2025 |
| IPO Close | Nov 25, 2025 |
| Allotment | Nov 26, 2025 |
| Refunds | Nov 27, 2025 |
| Listing | Nov 28, 2025 |
| Anchor Bidding | Nov 20, 2025 |
❓ Sudeep Pharma IPO: FAQs
Q. What is the Sudeep Pharma IPO issue size?
₹895 crore.
Q. What is the price band?
₹563–₹593 per share.
Q. When is the allotment?
November 26, 2025.
Q. When will the IPO list?
November 28, 2025 on BSE & NSE.
Q. How to apply?
Through ASBA/UPI using your bank or stockbroker.